Particulate matter in parenteral drugs has been a known issue for over two centuries. Particular matter could come from any little thing that is involved in the process of making the drug product. Contaminants could come from the environment, packaging for the product, ingredients in the product, reactions of the formula and anything that could…
Read more
Improving Visual Inspection Practices
Improving Visual Inspection Practices, written by Jennifer Markarian with Pharmaceutical Technology, she interviews John Shabushnig, PhD and talks about the need of improving the understanding and practice of visual inspection of parenteral drugs. Their interview gives guidance of where to search for help, as well as what is recommended. PDA and USP have been working together…
Read more
Avoiding Glass Delamination
Cleanroon Technology published an article in 2011 titled Avoiding Glass Delamination. Delamination is where a material fractures into layers; it is a mode of failure and is unsafe in many scenarios. Delamination of a glass container carrying parenteral drugs has resulted in many drug recalls. This leads to particles in the drug itself; such as…
Read more
The Future Of Wearable Injectors
Around the world people are believing that wearable injectors are expensive and complex. Jesper Roested, Chief Executive Officer of Subcuject, explains how those beliefs could be false. Jesper Roested expressed that this technology is part of the modern-day pharma industry; the at-home industry is rapidly growing. The pharmaceutical industry is shifting towards patient-centric and putting…
Read more